Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.45 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1149470 | 1.00 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL4771744 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Bromide SCHEMBL583318 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL8209880 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL4134315 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL649131 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL23320287 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL980555 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL3415840 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL10000698 | 0.94 | SIGMAR1 (0.44) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955414-B | Amphiphilic Eu complex, preparation method thereof and application thereof in tetracycline detection | 南昌大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119192465-A | Preparation method and application of polymer-gadolinium hybrid contrast agent | 青岛科技大学 | 2024-12-27 | — | — | CN | claimed |
| CN-118955414-A | Amphiphilic Eu complex, preparation method thereof and application thereof in tetracycline detection | 南昌大学 | 2024-11-15 | — | — | CN | claimed |
| CN-114014540-B | Preparation process of opal quartz glass | 连云港太平洋半导体材料有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114014540-A | Preparation process of opal quartz glass | 连云港太平洋半导体材料有限公司 | 2022-02-08 | — | — | CN | claimed |
| US-20200030716-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2020-01-30 | — | — | US | claimed |
| US-9981953-B1 | Contrast agent precursor and method for preparing the same | Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. (TW) | 2018-05-29 | — | — | US | claimed |
| EP-2547369-B1 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK-COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | UNIV KING SAUD (SA) | 2017-04-19 | — | — | EP | claimed |
| WO-2001052899-A1 | CHELATING AGENTS AND METHOD FOR THEIR USE AS TANDEM METAL CHELATORS AND HYDROPHILIC SPACERS FOR MEDICAL DIAGNOSIS AND THERAPY | MALLINCKRODT INC. (US) | 2001-07-26 | — | — | WO | claimed |
| US-12637398-B2 | Radiohalogen prosthetic moieties and radiolabeled biomolecules | DUKE UNIVERSITY (US) | 2026-05-26 | — | — | US | disclosed |
| CN-119661737-B | Polysaccharide contrast agent capable of being metabolized by kidneys and preparation method thereof | 四川大学 | 2026-05-22 | — | — | CN | disclosed |
| CN-122070148-A | Inhibitors of targeted fibroblast activation proteins | 苏州博锐创合医药有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026086847-A1 | CYCLOPEPTIDE DRUG CONJUGATE AND USE THEREOF | 中山医诺维申新药研发有限公司 | 2026-04-30 | — | — | WO | disclosed |
| US-20260083864-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | BAYER AG (DE) | 2026-03-26 | — | — | US | disclosed |
| WO-1995001346-A1 | CHELATING COMPOUNDS | AKZO NOBEL N.V. (NL) | 1995-01-12 | — | — | WO | disclosed |
| US-5198208-A | Chelate compounds for diagnosis by magnetic resonance imaging, ultrasound or radiation therapy | NYCOMED IMAGING AS (NO) | 1993-03-30 | — | — | US | disclosed |
| EP-0497926-A1 | MULTI-SITE METAL CHELATING AGENTS | NYCOMED SALUTAR, INC. (US) | 1992-08-12 | — | — | EP | disclosed |
| EP-0466200-A1 | Aminocarboxylic acids and derivatives thereof | NYCOMED IMAGING AS (NO) | 1992-01-15 | — | — | EP | disclosed |
| WO-1991005762-A1 | MULTI-SITE METAL CHELATING AGENTS | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1991-05-02 | — | — | WO | disclosed |
| WO-1989000557-A1 | AMINOPOLYCARBOXYLIC ACIDS AND DERIVATIVES THEREOF | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1989-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200030716-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | SOD1, SOD3, SLC39A11 | SIGMAR1 3543/4885CHRM3 1662/4885CHRM5 1660/4885 |
| US-20260083864-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | CA13, CCR1, GALC | SIGMAR1 1089/4885CHRM3 135/4885CHRM5 424/4885 |
| US-12637398-B2 | Radiohalogen prosthetic moieties and radiolabeled biomolecules | CD47, KLK3, SHBG | SIGMAR1 3220/4885CHRM3 2937/4885CHRM5 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.